Study reveals recommended anticoagulant therapy for COVID patients

Close Up Scientist using microscope in laboratory room while making medical testing and research

The AustralaSian COVID-19 Trial (ASCOT) has pinpointed the most efficient level of blood thinning treatment needed for patients hospitalized with COVID-19, in a study published in the New England Journal of Medicine Evidence and presented at the American Society for Hematology conference today.

Troubleshooting the mystery of post-COVID insomnia with a sleep tracker

Previous article

‘SNL’ cast shares how to keep your cool in a very special Christmas cold open

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations